NCT04251052 2026-03-27
A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NRG Oncology
Phase NA Recruiting
Clinical Trials
12 trialsNCT04604613 2026-03-09
Prediction of Recurrence Among Low Risk Endometrial Cancer Patients
M.D. Anderson Cancer Center
Active not recruiting
NCT00066690 2026-02-06
SOFT
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT02760849 2026-01-07
Surgery in Preventing Ovarian Cancer in Patients With Genetic Mutations
M.D. Anderson Cancer Center
Phase NA Active not recruiting
NCT05801705 2023-05-18
Comparative Evaluation of Efficacy and Safety of Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian Function Suppression in Hormone Receptor-Positive Early Breast Cancer Among Non-Low-Risk Premenopausal Women: A Real-World Study
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Unknown
NCT00066807 2016-10-28
PERCHE
ETOP IBCSG Partners Foundation
Phase 3 Terminated
NCT00293540 2016-07-27
Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer
International Breast Cancer Research Foundation
Phase 3 Completed
NCT00201851 2015-04-29
Adjuvant Oophorectomy and Tamoxifen in Premenopausal Women With Hormone Receptor-Positive Breast Cancer
International Breast Cancer Research Foundation
Phase 3 Completed
NCT00002580 2013-11-06
Tamoxifen, Ovarian Ablation, and/or Combination Chemotherapy in Treating Premenopausal Women With Stage I, Stage II, or Stage IIIA Invasive Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00084370 2013-08-22
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
University of Alabama at Birmingham
Phase NA Withdrawn
NCT00002460 2013-08-07
Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00002582 2013-08-02
Tamoxifen, Ovarian Ablation, and/or Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed